Study of Quadrivalent Influenza Vaccine Among Children

Study of Quadrivalent Influenza Vaccine Among Children
Study Type: Interventional
Age/Gender Requirements: 6 months to 8 years (male/female)
Sponsor: Sanofi-Aventis
Purpose: This study is being conducted to evaluate a prototype quadrivalent influenza vaccine (QIV), the licensed 2010-2011 trivalent influenza vaccine (TIV) containing the primary B strain, and the investigational TIV containing the alternate B strain in children aged 6 months to less than 9 years of age.
http://hcp.lv/9It1Hh